A Sister event: Balticum Organicum Syntheticum 2022

We are happy to advertise an excellent conference organized in Vilnius couple of weeks later than Chemical Sciences in Biological Challenges. The BOS 2022 will be organized from 3rd to 6th of July and it covers both academic and industrial interests in the field of organic synthesis. The BOS 2022 website mentions the following as the goals of the conference:

  • to provide a forum for synthetic organic chemists from the entire world to speak of their work and discuss important scientific problems
  • to promote discussion between academic and industrial scientists about the possibilities of mutual cooperation
  • to present a unique cultural, linguistic and social experience for participants and accompanying persons

For more information, please visit: https://boschem.eu/bos2022/

CSBC Goes MDPI Special Issues!

We are happy to launch two Special Issues related to the CSBC Conference. The Special Issues are entitled “Medicinal Chemistry in Biological Challenges” and “Chemosensors in Biological Challenges” and are published by Pharmaceuticals (IF 5.863) and Chemosensors (IF 3.398), respectively. Both journals are Open Access and published by MDPI. The special issues cover the same scientific areas as our Conference. All the participants are invited to publish in these Special Issues, but the publishing is not limited to participants.

For more information about publishing in these Special Issues, please visit the webpages:

Chemosensors in Biological Challenges: https://www.mdpi.com/journal/chemosensors/special_issues/biological_sensors

Medicinal Chemistry in Biological Challenges: https://www.mdpi.com/journal/pharmaceuticals/special_issues/MC_Bio

Juri Timonen & Petri Turhanen,

Guest Editors

FEBS National Lecture award to Professor Finnbar O’Harte

Federation of European Biological Societies (FEBS) has nominated Professor Finnbar O’Harte (Ulster University, UK) as a recipient of FEBS National Lecture award. The award will be presented at Chemical Sciences in Biological Challenges Symposium at Kuopio, Finland, June 3-5, 2020. Professor O’Harte has made fundamental contributions in development of stable peptide analogues for therapy of Type 2 diabetes and obesity. In the symposium he will deliver a talk “Apelin-13 peptide analogues versus incretin mimetics for alleviating metabolic dysfunction in diabetes: A comparative study”